Home > Industry > Automotive

Industry 01 · Top Vertical

Pharma DTC

For regulated direct-to-consumer healthcare brands

In pharma, the goal is not just reach. It is education, condition relevance, patient action, and measurable prescription movement — all within FDA, MLR, and privacy constraints.

CORE CONVICTIONS.

Brand Signals

  • Condition awareness lift

  • Aided and unaided brand awareness lift

  • Brand-condition association lift

  • Message recall lift

  • “Talk to your doctor” intent lift

Intent Signals

  • Branded and condition search lift

  • Doctor discussion guide engagement

  • Co-pay or savings-card engagement

  • Patient support program engagement

  • HCP-locator lift, where applicable

Business Outcomes

  • Incremental new prescriptions

  • Incremental patient starts

  • Refill or adherence lift

  • Therapy initiation lift

Acquisition Efficiency

  • Cost per qualified patient action

  • Cost per savings-card download

  • Cost per doctor discussion guide download

  • Cost per patient support enrollment

  • Cost per incremental NRx, where measurable

Home > Industry > Pharma DTC

Industry 03 · High Fit · Regulated

Pharma DTC

The pressure you're under:

Your media plan has to satisfy MLR review, FDA fair-balance requirements, brand-safety standards your legal team can defend, and a CFO who wants to see incremental script lift — not just impressions. Most agencies don't understand the regulatory layer, and the ones that do are charging you a premium for the privilege of compliance theater. Meanwhile, 58% of pharma marketers plan to increase CTV spend in 2026, and your team is being asked to scale into a channel without a partner who can navigate it cleanly.

Where CTV solves it:

CTV gives DTC pharma the brand-safe, premium-environment, household-precision targeting that linear can't and that social media won't risk. We work inside MLR-reviewed creative workflows, run HIPAA-aware audience targeting where the data partner allows, and stay inside premium streaming inventory — never on long-tail or open-exchange placements that introduce brand-safety exposure. Reporting is structured for compliance review, not just media review.

The KPIs we'll be accountable to:

Cost per branded search

Cost per HCP locator visit

Incremental Rx lift in test markets vs. holdout

Reach against verified in-market patient audiences

Brand favorability lift in adjacency-controlled studies

Built for the pharma DTC CMO whose media plan has to clear MLR, satisfy the CFO, and grow scripts in the same quarter — without inviting a brand-safety incident.